Salt Lake City, UT (PRWEB) July 19, 2013
TFX Health, LLC announced earlier this week that it has released dozens of new “Mobile-Friendly” websites for its popular TFX Flex™ Joint Health Supplement. Since its introduction at GNC earlier this year, TFX Flex™ has turned the joint health industry upside down with its revolutionary new dietary ingredient that has been shown in human clinical studies to be 2X more effective than Glucosamine & Chondroitin for joint pain relief. In a short time, TFX Flex™ has become GNC’s best selling triple threat product for bone, joint, and muscle support.
A TFX Health company spokesman explained, “we live in a world on the move and the mobile marketing landscape is booming with more and more consumers choosing to shop on mobile devices. The optimized mobile websites provide another important tool to make TFX Flex™ available to a wider market.” The company reported an immediate increase in website visits and online sales within days of releasing the new mobile websites.
To take advantage of mobile shopping trends, more companies are moving to mobile compatible websites with mixed results. Making the jump into the mobile arena has proven challenging for many companies. According to hasoffers.com, an industry leader in online marketing analytics, “It can be quite painful when trying to navigate a website that has excessive content and too many options. This only frustrates the user and provides them with a terrible experience.”
Compared to desktops, mobile devices have extreme space limitations, a more simplistic approach must be taken to limit options and reduce content, yet still deliver value and compelling offers. Mobile devices come in different formats and a myriad of screen sizes so creating an optimal mobile friendly website has become both an art and a science. For those companies that master both, the rewards can be significant and immediate.
TFX Health, LLC has committed to stay ahead of the curve on both internet marketing technology and health and wellness products following the mantra “cutting edge products available through cutting edge distribution channels.” Marketing TFX Flex™ through mobile channels is consistent with this mantra.
TFX Flex™ contains UC-II®, a breakthrough new dietary ingredient proven in human clinical studies to be 2X more effective than Glucosamine & Chondroitin for joint pain relief. UC-II® was developed by a team of scientists with more than 25 years of experience and is supported by nine clinical studies. It holds seven international and U.S. patents.
In a randomized, double-blind, placebo-controlled human clinical study it was found that only 40 mg of UC-II® Undenatured Type II Collagen was more than two times as effective as 1,500 mg of glucosamine and 1,200 mg of chondroitin in supporting joint health, comfort and flexibility. It outperformed the glucosamine & chondroitin combination in three different joint pain relief assessment tools: WOMAC, VAS and the Lequesne Functional Index. UC-II® significantly decreased joint pain during daily activities, including walking on a flat surface, performing heavy domestic duties, ascending stairs and while resting in bed. UC-II® was also shown to be safe and well tolerated with no known side effects [Crowley DC, Lau FC, Sharma P, et al. Int J Med Sci. 2009; 6:312-321].
Glucosamine & Chondroitin came under fire after a 2010 study published in the British Medical Journal concluded that, “Glucosamine and Chondroitin, either taken together or separately, have not shown a clinically significant improvement in joint pain relief for patients troubled with knee or hip osteoarthritis [BMJ 2010; 341:c4675]. With worldwide annual sales of Glucosamine & Chondroitin in excess of $2 Billion, there appears to be room for new and better alternatives.
About TFX Health, LLC
Based in Salt Lake City, TFX Health, LLC is an innovative pioneer in the development of advanced health and wellness products. Its brands include TFX Flex™ Joint Health Supplement, TFX Drive™ Testosterone Booster, TFX Elite™ Extreme Thermogenic, and other high end formulations. TFX Health products are manufactured in the USA in FDA registered, GMP compliant facilities and sold worldwide through online and traditional retail channels. For more information, please visit http://www.TFXflex.com/
UC-II® is a trademark of InterHealth N.I. Clinical data available upon request. U.S. Patents 5,645,851; 5,637,321; 5,529,786; 5,750,144; 7,083,820; 7,846,487, EPO Patent 1435906B1 and worldwide patents pending.
Read the full story at http://www.prweb.com/releases/2013/7/prweb10934631.htm.
Copyright©2012 Vocus, Inc.
All rights reserved